Akio Kawamura

Efficacy of 15 mg Edoxaban on Long-Term Outcome after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation and High Bleeding Risk.

Journal: International heart journal

Published: July 15, 2026

Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study.

Journal: Journal of atherosclerosis and thrombosis

Published: April 08, 2026

Sinus arrest in a patient with acute coronary syndrome due to a rare anatomical variation in the sinoatrial nodal artery.

Journal: BMC cardiovascular disorders

Published: March 07, 2026

Dose-dependent effects of oral semaglutide on arterial stiffness and the additive role of SGLT-2 inhibitors in type 2 diabetes.

Journal: British journal of clinical pharmacology

Published: November 03, 2025

Relationship of Depression With Incident Cardiovascular Disease in Individuals With Chronic Kidney Disease.

Journal: Circulation reports

Published: October 21, 2025

Real-World Patent Foramen Ovale Closure in Japan　- Results From 1-Year Follow-up of the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: June 15, 2025

Dual impact of anaemia and chronic kidney disease on postpercutaneous coronary intervention outcomes: insights from the Japanese nationwide registry.

Journal: Open heart

Published: December 22, 2024

Real-World Patent Foramen Ovale (PFO) Closure in Japan　- 30-Day Clinical Outcomes From the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: May 12, 2024

Leadless pacemaker infection: usefulness of positron emission tomography/computed tomography.

Journal: BMJ case reports

Published: May 08, 2024

J wave dynamicity during coronary angiography and intracoronary acetylcholine administration.

Journal: Pacing and clinical electrophysiology : PACE

Published: May 30, 2023

Usefulness of Global Longitudinal Strain-Guided Management in Preventing Human Epidermal Growth Factor Receptor 2 (HER2) Inhibitor-Induced Myocardial Damage.

Journal: Circulation reports

Published: September 06, 2022

Are we ready for building transition programs for heart transplant recipients in Japan? - Knowing the unique background is the first step for discussion.

Journal: Frontiers in pediatrics

Published: May 03, 2022

Efficacy of 15 mg Edoxaban on Long-Term Outcome after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation and High Bleeding Risk.

Efficacy of 15 mg Edoxaban on Long-Term Outcome after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation and High Bleeding Risk.

Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study.

Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study.

Sinus arrest in a patient with acute coronary syndrome due to a rare anatomical variation in the sinoatrial nodal artery.

Sinus arrest in a patient with acute coronary syndrome due to a rare anatomical variation in the sinoatrial nodal artery.

Dose-dependent effects of oral semaglutide on arterial stiffness and the additive role of SGLT-2 inhibitors in type 2 diabetes.

Dose-dependent effects of oral semaglutide on arterial stiffness and the additive role of SGLT-2 inhibitors in type 2 diabetes.

Relationship of Depression With Incident Cardiovascular Disease in Individuals With Chronic Kidney Disease.

Relationship of Depression With Incident Cardiovascular Disease in Individuals With Chronic Kidney Disease.

Real-World Patent Foramen Ovale Closure in Japan - Results From 1-Year Follow-up of the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Real-World Patent Foramen Ovale Closure in Japan - Results From 1-Year Follow-up of the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Dual impact of anaemia and chronic kidney disease on postpercutaneous coronary intervention outcomes: insights from the Japanese nationwide registry.

Dual impact of anaemia and chronic kidney disease on postpercutaneous coronary intervention outcomes: insights from the Japanese nationwide registry.

Real-World Patent Foramen Ovale (PFO) Closure in Japan - 30-Day Clinical Outcomes From the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Real-World Patent Foramen Ovale (PFO) Closure in Japan - 30-Day Clinical Outcomes From the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Leadless pacemaker infection: usefulness of positron emission tomography/computed tomography.

Leadless pacemaker infection: usefulness of positron emission tomography/computed tomography.

J wave dynamicity during coronary angiography and intracoronary acetylcholine administration.

J wave dynamicity during coronary angiography and intracoronary acetylcholine administration.

Usefulness of Global Longitudinal Strain-Guided Management in Preventing Human Epidermal Growth Factor Receptor 2 (HER2) Inhibitor-Induced Myocardial Damage.

Usefulness of Global Longitudinal Strain-Guided Management in Preventing Human Epidermal Growth Factor Receptor 2 (HER2) Inhibitor-Induced Myocardial Damage.

Are we ready for building transition programs for heart transplant recipients in Japan? - Knowing the unique background is the first step for discussion.

Are we ready for building transition programs for heart transplant recipients in Japan? - Knowing the unique background is the first step for discussion.

Real-World Patent Foramen Ovale Closure in Japan　- Results From 1-Year Follow-up of the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Real-World Patent Foramen Ovale Closure in Japan　- Results From 1-Year Follow-up of the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Real-World Patent Foramen Ovale (PFO) Closure in Japan　- 30-Day Clinical Outcomes From the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.

Real-World Patent Foramen Ovale (PFO) Closure in Japan　- 30-Day Clinical Outcomes From the AmplatzerTM PFO Occluder Japan Post-Marketing Surveillance Study.